Elacestrant Dihydro chloride

An antibiotic that blocks synthesis of dihydrofolic acid by inhibiting the enzyme dihydropteroate synthase

Deutetrabenazine is a first-in-class, orally bioavailable deuterated vesicular monoamine transporter 2 (VMAT2) inhibitor approved for the treatment of chorea associated with Huntington’s disease and tardive dyskinesia. 

Methylboronic Acid-d₃ (CD₃B(OH)₂) is a high-purity deuterated organoboron building block widely used in the synthesis of stable isotope-labeled pharmaceuticals, advanced intermediates, and analytical reference standards. It is an essential reagent for Suzuki–Miyaura cross-coupling reactions, enabling the e...

Methyl iodide-d₃ (CD₃I) is a high-purity deuterated methylating reagent widely used in the synthesis of stable isotope-labeled pharmaceuticals, intermediates, metabolites, and analytical reference standards. It enables the efficient incorporation of a deuterated methyl (–CD₃) group into complex organic mol...

Methyl Tosylate-d₃ (CD₃OTs) is a high-purity deuterated methylating reagent widely used in the synthesis of stable isotope-labeled pharmaceuticals, intermediates, and analytical reference standards. It enables the efficient introduction of a deuterated methyl (–CD₃) group into target molecules, making it a...

Methylamine-d₃ Hydrochloride serves as a key deuterated building block for introducing a CD₃-labeled methylamine moiety into complex organic molecules. It is extensively used in the preparation of deuterated drug candidates, impurities, and metabolites, including compounds such as: Deucravacitinib-d₃ ...

High-purity Elacestrant Impurity 3   is a key chemical intermediate and structural analogue involved in the synthesis of Elacestrant. It serves as a vital building block for active pharmaceutical ingredient (API) manufacturing and as an analytical reference standard for impurity profiling, method...

N-Ethyl-2-(4-formylphenyl)acetamide is an essential organic intermediate and structural fragment used in the multi-step chemical synthesis of Elacestrant. It acts as a key building block during late-stage coupling reactions and serves as a vital analytical reference standard for impurity profiling, method ...

Ruxolitinib is an orally active, potent, and selective Janus kinase (JAK1 and JAK2) inhibitor. It is indicated for the treatment of myelofibrosis, polycythemia vera, graft-versus-host disease (GvHD), and atopic dermatitis/vitiligo (topical formulation). Manufactured under strict GMP guidelines for use in p...

2-(3,4-bis(methoxy-d3)phenyl)ethan-1-amine is an advanced deuterated intermediate essential for the commercial synthesis and manufacturing of Deutetrabenazine (API)

Acetone-d₆ is a versatile deuterated reagent and solvent designed for stable isotope labeling applications. It is extensively used in the synthesis of deuterated APIs, intermediates, metabolites, and analytical reference standards. Its high isotopic purity ensures reliable deuterium incorporation, making i...

Lisdexamfetamine Dimesylate is a central nervous system (CNS) stimulant active pharmaceutical ingredient (API) and prodrug indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and binge eating disorder (BED). Enzymatically hydrolyzed in red blood cells to release active dextroamph...

Clearsynth Labs Limited is a technology-based, research-driven, innovation-led enterprise specializing in deuterium chemistry and stable isotopes. Headquartered in Mumbai, with an R&D center in Hyderabad and a CDMO facility in Karnataka, alongside operations in Canada and the USA, we deliver solutions from milligram-scale R&D to multi-ton manufacturing. Our expertise spans deuterated APIs, intermediates, impurities, and reference standards. Backed by strong IP and 350+ scientists, we partner with innovators and generics across CDMO and CMO segments, committed to precision, quality, and advancing next-generation isotopic solutions for global pharmaceutical needs.